Multifunctional Supramolecular Vesicles as Zn 2+ ‐Triggered Microglial Modulator Alleviates Alzheimer's Disease
Small · 2023
DOI: 10.1002/smll.202302176 ↗Kurz gefasst
Fachartikel in der Zeitschrift Small, 2023. Verfasst von Zhi Jia und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, College of Chemistry and Materials Science, Jinan University, Guangzhou, 510632, China. Hauptthemen laut MEDLINE: Alzheimer Disease. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 56 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Guangdong Province.
Themen: Demenz
Abstract (Originalsprache)
Zn 2+ ‐induced β‐amyloid protein (Aβ) aggregation and microglia activation are the predominant contributors in Alzheimer's disease (AD). Regulating intracephalic excessive Zn 2+ is a promising therapeutic strategy for AD treatment. However, only inhibition of Zn 2+ is hardly to repair continuous damages caused by activated microglia. Herein, an intelligent resveratrol‐loaded supramolecular vesicles (RES‐loaded vesicles) with zinc ion chelation function and responsive release capability are constructed to alleviate Aβ fibrillation, oxidative stress, and microglial dysfunction. The resveratrol encapsulation efficiency and drug loading efficiency are calculated to be 49.67% and 7.87%, respectively. In vitro studies demonstrate that the RES‐loaded vesicles can modulate Zn 2+ ‐dependent Aβ aggregation. More importantly, the cargoes will be released in zinc environment and further reprograms microglia from proinflammatory M1 phenotype toward anti‐inflammatory M2 phenotype, which prevents spontaneous neuroinflammation and alleviates cytotoxicity of cultured cells from 29% to 12%. With the stereotactic or intranasal administration, RES‐loaded vesicles can overcome the blood brain barrier, alleviate neuronal apoptosis, neuroinflammation, and ultimately ameliorate cognitive impairment in two AD mouse models. This work provides a new sight for taking advantage of Zn 2+ to treat CNS disorders.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Chemistry, College of Chemistry and Materials Science, Jinan University, Guangzhou, 510632, China.
- State Key Laboratory of Luminescent Materials and Devices, School of Chemistry and Chemical Engineering, South China University of Technology, Guangzhou, 510641, China.
ORCID-Profile: Jie Liu
Förderung
- National Natural Science Foundation of China
- Natural Science Foundation of Guangdong Province
Zitieren
APA
Jia, Z., Tang, R., Yuan, X., Zhu, H., Guo, J., Chen, Y., Yang, Y., Liang, B., Lu, S., Cao, D., & Liu, J. (2023). Multifunctional Supramolecular Vesicles as Zn 2+ ‐Triggered Microglial Modulator Alleviates Alzheimer's Disease. Small. https://doi.org/10.1002/smll.202302176
Vancouver
Jia Z, Tang R, Yuan X, Zhu H, Guo J, Chen Y, et al. Multifunctional Supramolecular Vesicles as Zn 2+ ‐Triggered Microglial Modulator Alleviates Alzheimer's Disease. Small. 2023. doi:10.1002/smll.202302176
BibTeX
@article{Jia2023,
author = {Jia, Zhi and Tang, Ran and Yuan, Xiaoyu and Zhu, Hengmin and Guo, Jiaqi and Chen, Yutong and Yang, Yonglan and Liang, Bin and Lu, Shuhao and Cao, Derong and Liu, Jie},
title = {Multifunctional Supramolecular Vesicles as Zn 2+ ‐Triggered Microglial Modulator Alleviates Alzheimer's Disease},
journal = {Small},
year = {2023},
doi = {10.1002/smll.202302176}
}
EUVIMED